1. Home
  2. JSPRW vs PEBO Comparison

JSPRW vs PEBO Comparison

Compare JSPRW & PEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JSPRW
  • PEBO
  • Stock Information
  • Founded
  • JSPRW N/A
  • PEBO 1902
  • Country
  • JSPRW United States
  • PEBO United States
  • Employees
  • JSPRW 45
  • PEBO N/A
  • Industry
  • JSPRW Biotechnology: Pharmaceutical Preparations
  • PEBO Major Banks
  • Sector
  • JSPRW Health Care
  • PEBO Finance
  • Exchange
  • JSPRW Nasdaq
  • PEBO Nasdaq
  • Market Cap
  • JSPRW N/A
  • PEBO N/A
  • IPO Year
  • JSPRW 2020
  • PEBO N/A
  • Fundamental
  • Price
  • JSPRW $0.15
  • PEBO $32.49
  • Analyst Decision
  • JSPRW
  • PEBO Buy
  • Analyst Count
  • JSPRW 0
  • PEBO 5
  • Target Price
  • JSPRW N/A
  • PEBO $37.90
  • AVG Volume (30 Days)
  • JSPRW N/A
  • PEBO 146.9K
  • Earning Date
  • JSPRW N/A
  • PEBO 01-21-2025
  • Dividend Yield
  • JSPRW N/A
  • PEBO 4.89%
  • EPS Growth
  • JSPRW N/A
  • PEBO N/A
  • EPS
  • JSPRW N/A
  • PEBO 3.31
  • Revenue
  • JSPRW N/A
  • PEBO $423,280,000.00
  • Revenue This Year
  • JSPRW N/A
  • PEBO N/A
  • Revenue Next Year
  • JSPRW N/A
  • PEBO $4.40
  • P/E Ratio
  • JSPRW N/A
  • PEBO $9.88
  • Revenue Growth
  • JSPRW N/A
  • PEBO 2.93
  • 52 Week Low
  • JSPRW N/A
  • PEBO $26.74
  • 52 Week High
  • JSPRW N/A
  • PEBO $37.07
  • Technical
  • Relative Strength Index (RSI)
  • JSPRW N/A
  • PEBO 48.84
  • Support Level
  • JSPRW N/A
  • PEBO $32.60
  • Resistance Level
  • JSPRW N/A
  • PEBO $33.41
  • Average True Range (ATR)
  • JSPRW 0.00
  • PEBO 0.78
  • MACD
  • JSPRW 0.00
  • PEBO 0.06
  • Stochastic Oscillator
  • JSPRW 0.00
  • PEBO 47.86

About JSPRW Japer Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: